Tarsus Pharmaceuticals, Inc. ($TARS)
Filing Information
| Accession Number | 0001405253-26-000005 |
|---|---|
| Form Type | 4 |
| Filing Date | Mar 17, 2026 |
| Document | View SEC Filing |
Transactions
3
Total Shares
26,084
Total Value
$0.00
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer and Chief Strategy Officer | Common Stock | โ | Mar 15, 2026 | Exercise/Conversion | 13,042 | โ | โ | 49,746 | Direct | โ | View Details | |
Chief Financial Officer and Chief Strategy Officer | Restricted Stock Units | Derivative | Mar 15, 2026 | Exercise/Conversion | 8,020 | $0.00 | $0.00 | 16,040 | Direct | โ | View Details | |
Chief Financial Officer and Chief Strategy Officer | Restricted Stock Units | Derivative | Mar 15, 2026 | Exercise/Conversion | 5,022 | $0.00 | $0.00 | 15,067 | Direct | โ | View Details |